首页 > 最新文献

Journal of Anaesthesiology Clinical Pharmacology最新文献

英文 中文
Comparison of ultrasonographic measurement of gastric antral volume and pH with or without pharmacological acid aspiration prophylaxis in low-risk surgical patients – A randomized clinical trial 在低风险外科手术患者中使用或不使用药物预防吸酸法进行胃前区容积和 pH 值超声波测量的比较 - 一项随机临床试验
Pub Date : 2024-04-11 DOI: 10.4103/joacp.joacp_412_22
Balaji Kannamani, S. Panneerselvam, P. Rudingwa, A. S. Badhe, K. Govindaraj, Srivats Ramamoorthy
The role of preoperative pharmacological prophylaxis in preventing aspiration pneumonitis under general anesthesia (GA) in patients at low risk of aspiration pneumonitis is still under debate. We addressed the need for routine pharmacological aspiration prophylaxis in at-risk population by assessing the change in gastric volume using ultrasound with and without pharmacological acid aspiration prophylaxis. A single-center, randomized double-blinded trial, with 200 adult patients scheduled for elective surgical procedures under GA, were randomized into a prophylaxis group, in which the patients received oral famotidine and metoclopramide, and a no prophylaxis group, in which the patients did not receive any prophylaxis. Gastric volume derived from preinduction measurement of gastric antral volume by ultrasound, postinduction gastric pH, and incidences of aspiration pneumonitis were compared. Bland–Altman plot was used to determine the level of agreement between measured gastric volume and ultrasonography based on calculated gastric volume. The gastric antral cross-sectional area (CSA) and volume in the no prophylaxis group (3.12 cm2 and 20.11 ml, respectively) were comparable to the prophylaxis group (2.56 cm2 and 19.67 ml, respectively) (P-values 0.97 and 0.63, respectively). Although there was a statistically significant decrease in gastric pH in the no prophylaxis group (P-value 0.01), it was not clinically significant to increase the risk of aspiration pneumonitis based on Roberts and Shirley criteria (P-value 0.39). In an adequately fasted low-risk population, the amount of residual gastric volume was similar and below the aspiration threshold, regardless of the aspiration prophylaxis status.
对于吸入性肺炎的低风险患者,术前药物预防在全身麻醉(GA)中预防吸入性肺炎的作用仍存在争议。我们通过使用超声波评估使用和不使用药物预防吸入胃酸时胃容量的变化,来探讨在高危人群中常规使用药物预防吸入性肺炎的必要性。 这是一项单中心、随机双盲试验,共有 200 名成人患者计划在 GA 下进行择期手术,他们被随机分为预防组和非预防组,预防组患者口服法莫替丁和甲氧氯普胺,非预防组患者不服用任何预防药物。比较了诱导前通过超声波测量胃前区容积得出的胃容量、诱导后的胃 pH 值以及吸入性肺炎的发病率。使用Bland-Altman图确定测量的胃容积与超声波检查计算的胃容积之间的一致程度。 未采取预防措施组的胃前部横截面积(CSA)和胃容量(分别为 3.12 平方厘米和 20.11 毫升)与采取预防措施组(分别为 2.56 平方厘米和 19.67 毫升)相当(P 值分别为 0.97 和 0.63)。虽然未采取预防措施组的胃 pH 值在统计学上显著下降(P 值为 0.01),但根据罗伯茨和雪莉标准,这对增加吸入性肺炎的风险并无临床意义(P 值为 0.39)。 在充分禁食的低风险人群中,无论采取何种吸入预防措施,残胃量都相似且低于吸入阈值。
{"title":"Comparison of ultrasonographic measurement of gastric antral volume and pH with or without pharmacological acid aspiration prophylaxis in low-risk surgical patients – A randomized clinical trial","authors":"Balaji Kannamani, S. Panneerselvam, P. Rudingwa, A. S. Badhe, K. Govindaraj, Srivats Ramamoorthy","doi":"10.4103/joacp.joacp_412_22","DOIUrl":"https://doi.org/10.4103/joacp.joacp_412_22","url":null,"abstract":"\u0000 \u0000 \u0000 The role of preoperative pharmacological prophylaxis in preventing aspiration pneumonitis under general anesthesia (GA) in patients at low risk of aspiration pneumonitis is still under debate. We addressed the need for routine pharmacological aspiration prophylaxis in at-risk population by assessing the change in gastric volume using ultrasound with and without pharmacological acid aspiration prophylaxis.\u0000 \u0000 \u0000 \u0000 A single-center, randomized double-blinded trial, with 200 adult patients scheduled for elective surgical procedures under GA, were randomized into a prophylaxis group, in which the patients received oral famotidine and metoclopramide, and a no prophylaxis group, in which the patients did not receive any prophylaxis. Gastric volume derived from preinduction measurement of gastric antral volume by ultrasound, postinduction gastric pH, and incidences of aspiration pneumonitis were compared. Bland–Altman plot was used to determine the level of agreement between measured gastric volume and ultrasonography based on calculated gastric volume.\u0000 \u0000 \u0000 \u0000 The gastric antral cross-sectional area (CSA) and volume in the no prophylaxis group (3.12 cm2 and 20.11 ml, respectively) were comparable to the prophylaxis group (2.56 cm2 and 19.67 ml, respectively) (P-values 0.97 and 0.63, respectively). Although there was a statistically significant decrease in gastric pH in the no prophylaxis group (P-value 0.01), it was not clinically significant to increase the risk of aspiration pneumonitis based on Roberts and Shirley criteria (P-value 0.39).\u0000 \u0000 \u0000 \u0000 In an adequately fasted low-risk population, the amount of residual gastric volume was similar and below the aspiration threshold, regardless of the aspiration prophylaxis status.\u0000","PeriodicalId":508221,"journal":{"name":"Journal of Anaesthesiology Clinical Pharmacology","volume":"39 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140716221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nasal endotracheal intubation in a patient with difficult airway under ultrasonographic guidance 在超声引导下为困难气道患者进行鼻气管插管术
Pub Date : 2024-04-08 DOI: 10.4103/joacp.joacp_155_23
Sunil Rajan, N. Sasikumar, Jacob Mathew, SherjinDev S. Raveendran
{"title":"Nasal endotracheal intubation in a patient with difficult airway under ultrasonographic guidance","authors":"Sunil Rajan, N. Sasikumar, Jacob Mathew, SherjinDev S. Raveendran","doi":"10.4103/joacp.joacp_155_23","DOIUrl":"https://doi.org/10.4103/joacp.joacp_155_23","url":null,"abstract":"","PeriodicalId":508221,"journal":{"name":"Journal of Anaesthesiology Clinical Pharmacology","volume":"11 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140728514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The efficacy of ultrasound-guided upper thoracic erector spinae plane block for postoperative analgesia in proximal shoulder surgery and its effect on phrenic nerve function: A prospective exploratory study 超声引导下上胸竖脊平面阻滞用于肩关节近端手术术后镇痛的疗效及其对膈神经功能的影响:前瞻性探索研究
Pub Date : 2024-04-08 DOI: 10.4103/joacp.joacp_434_22
Deepak Kumar, P. Talawar, Mridul Dhar, Qumar Azam, D. Tripathy, Deepak Singla, Gaurav Jain, Sangadala Priyanka, Deepali Jamgade, Rekha
The upper thoracic (T2) erector spinae plane block (UT-ESPB) has been proposed as an alternative to interscalene brachial plexus block for postoperative analgesia in shoulder surgery. The current study was conducted to evaluate the same. Patients scheduled for shoulder surgery under general anesthesia (GA) received ultrasound-guided UT-ESPB. The outcomes measured were diaphragmatic movements, block characteristics, and quality of recovery at 24 h. A total of 43 patients were recruited. The incidence of phrenic nerve palsy was 0%. The sensory level achieved by the maximum number of patients at the end of 30 min was C7-T5 level, and none had a motor block. Forty-two percent of patients did not require rescue analgesia till 24 h postoperative. In the rest of the patients, the mean (SD) duration of analgesia was 724.2 ± 486.80 min, and the mean postoperative requirement of fentanyl was 98.80 ± 47.02 mg. The median pain score (NRS) during rest and movement is 2 to 3 and 3 to 4, respectively. The median quality of recovery score at the end of 24 h after the block was 14 (15–14). The upper thoracic ESPB resulted in a sensory loss from C7-T5 dermatomes without any weakness of the diaphragm and upper limb. However, the block was moderately effective in terms of the total duration of analgesia, postoperative pain scores, analgesic requirement, and quality of recovery in patients undergoing proximal shoulder surgeries under GA. Further studies are required to establish its role due to its poor correlation with sensory spread.
上胸椎(T2)竖脊肌平面阻滞(UT-ESPB)被认为是肩部手术术后镇痛的椎间臂丛阻滞替代方案。本研究就是为了对这一观点进行评估。 计划在全身麻醉(GA)下进行肩部手术的患者接受了超声引导下的UT-ESPB。共招募了 43 名患者,测量的结果包括膈肌运动、阻滞特征和 24 小时后的恢复质量。膈神经麻痹发生率为 0%。最多患者在 30 分钟结束时达到的感觉水平是 C7-T5 水平,没有人出现运动阻滞。42%的患者在术后 24 小时内不需要辅助镇痛。其余患者的平均(标清)镇痛时间为(724.2 ± 486.80)分钟,术后平均芬太尼用量为(98.80 ± 47.02)毫克。休息和运动时疼痛评分(NRS)的中位数分别为 2 至 3 分和 3 至 4 分。阻滞术后24小时恢复质量评分的中位数为14(15-14)分。 上胸椎ESPB导致C7-T5皮节感觉缺失,但膈肌和上肢没有任何无力感。不过,就镇痛总持续时间、术后疼痛评分、镇痛剂需求量和恢复质量而言,在GA下进行肩部近端手术的患者中,ESPB阻滞的效果一般。由于其与感觉扩散的相关性较差,还需要进一步研究以确定其作用。
{"title":"The efficacy of ultrasound-guided upper thoracic erector spinae plane block for postoperative analgesia in proximal shoulder surgery and its effect on phrenic nerve function: A prospective exploratory study","authors":"Deepak Kumar, P. Talawar, Mridul Dhar, Qumar Azam, D. Tripathy, Deepak Singla, Gaurav Jain, Sangadala Priyanka, Deepali Jamgade, Rekha","doi":"10.4103/joacp.joacp_434_22","DOIUrl":"https://doi.org/10.4103/joacp.joacp_434_22","url":null,"abstract":"\u0000 \u0000 \u0000 The upper thoracic (T2) erector spinae plane block (UT-ESPB) has been proposed as an alternative to interscalene brachial plexus block for postoperative analgesia in shoulder surgery. The current study was conducted to evaluate the same.\u0000 \u0000 \u0000 \u0000 Patients scheduled for shoulder surgery under general anesthesia (GA) received ultrasound-guided UT-ESPB. The outcomes measured were diaphragmatic movements, block characteristics, and quality of recovery at 24 h.\u0000 \u0000 \u0000 \u0000 A total of 43 patients were recruited. The incidence of phrenic nerve palsy was 0%. The sensory level achieved by the maximum number of patients at the end of 30 min was C7-T5 level, and none had a motor block. Forty-two percent of patients did not require rescue analgesia till 24 h postoperative. In the rest of the patients, the mean (SD) duration of analgesia was 724.2 ± 486.80 min, and the mean postoperative requirement of fentanyl was 98.80 ± 47.02 mg. The median pain score (NRS) during rest and movement is 2 to 3 and 3 to 4, respectively. The median quality of recovery score at the end of 24 h after the block was 14 (15–14).\u0000 \u0000 \u0000 \u0000 The upper thoracic ESPB resulted in a sensory loss from C7-T5 dermatomes without any weakness of the diaphragm and upper limb. However, the block was moderately effective in terms of the total duration of analgesia, postoperative pain scores, analgesic requirement, and quality of recovery in patients undergoing proximal shoulder surgeries under GA. Further studies are required to establish its role due to its poor correlation with sensory spread.\u0000","PeriodicalId":508221,"journal":{"name":"Journal of Anaesthesiology Clinical Pharmacology","volume":"138 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140731218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Occult foreign body in bronchus masquerading clinically as malignant hyperthermia 临床上伪装成恶性高热的支气管隐匿性异物
Pub Date : 2024-04-08 DOI: 10.4103/joacp.joacp_414_22
Deepak Modi, Manbir Kaur, Govind Singh, P. Bhatia
{"title":"Occult foreign body in bronchus masquerading clinically as malignant hyperthermia","authors":"Deepak Modi, Manbir Kaur, Govind Singh, P. Bhatia","doi":"10.4103/joacp.joacp_414_22","DOIUrl":"https://doi.org/10.4103/joacp.joacp_414_22","url":null,"abstract":"","PeriodicalId":508221,"journal":{"name":"Journal of Anaesthesiology Clinical Pharmacology","volume":"56 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140729888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Techniques of detecting recurrent laryngeal nerve palsy in patients undergoing thyroid surgery: Pearls and pitfalls 检测甲状腺手术患者喉返神经麻痹的技术:珍珠与陷阱
Pub Date : 2024-04-08 DOI: 10.4103/joacp.joacp_346_22
G. Chilkoti, Anju Gupta, Pallavi Bhandari, M. Mohta
Though permanent vocal cord palsy consequent to recurrent laryngeal nerve (RLN) injury is rare following thyroidectomies, its consequences are grave enough for it to be the most feared complication postoperatively. Anesthesiologists and surgeons take various precautions to prevent its occurrence and employ various methods for its early detection. They include direct visualization of the nerve intraoperatively, use of intraoperative nerve monitoring, and post-extubation visualization of vocal cord mobility by use of direct or indirect methods. In the present narrative review, we aim to discuss the clinical evidence pertaining to the various methods adopted for the prevention and early detection of RLN palsy during thyroidectomy.
虽然甲状腺切除术后因喉返神经(RLN)损伤而导致永久性声带麻痹的情况很少见,但其严重后果足以使其成为术后最令人担忧的并发症。麻醉师和外科医生采取了各种预防措施来防止喉返神经损伤的发生,并采用各种方法来早期发现喉返神经损伤。这些方法包括术中直接观察神经、术中使用神经监测、拔管后使用直接或间接方法观察声带活动度。在本综述中,我们旨在讨论在甲状腺切除术中采用各种方法预防和早期发现声带神经麻痹的相关临床证据。
{"title":"Techniques of detecting recurrent laryngeal nerve palsy in patients undergoing thyroid surgery: Pearls and pitfalls","authors":"G. Chilkoti, Anju Gupta, Pallavi Bhandari, M. Mohta","doi":"10.4103/joacp.joacp_346_22","DOIUrl":"https://doi.org/10.4103/joacp.joacp_346_22","url":null,"abstract":"\u0000 Though permanent vocal cord palsy consequent to recurrent laryngeal nerve (RLN) injury is rare following thyroidectomies, its consequences are grave enough for it to be the most feared complication postoperatively. Anesthesiologists and surgeons take various precautions to prevent its occurrence and employ various methods for its early detection. They include direct visualization of the nerve intraoperatively, use of intraoperative nerve monitoring, and post-extubation visualization of vocal cord mobility by use of direct or indirect methods. In the present narrative review, we aim to discuss the clinical evidence pertaining to the various methods adopted for the prevention and early detection of RLN palsy during thyroidectomy.","PeriodicalId":508221,"journal":{"name":"Journal of Anaesthesiology Clinical Pharmacology","volume":"89 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140728559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety of perioperative intravenous lidocaine in liver surgery – A pilot study 肝脏手术围手术期静脉注射利多卡因的安全性--一项试点研究
Pub Date : 2024-04-08 DOI: 10.4103/joacp.joacp_391_22
Pierre Grassin, Richard Descamps, J. Bourgine, Jean Lubrano, A. Fiant, Véronique Lelong-Boulouard, J. Hanouz
Perioperative lidocaine infusion has many interesting properties such as analgesic effects in the context of enhanced recovery after surgery. However, its use is limited in liver surgery due to its hepatic metabolism. This prospective, monocentric study was conducted from 2020 to 2021. Patients undergoing liver surgery were included. They received a lidocaine infusion protocol until the beginning of hepatic transection (bolus dose of 1.5 mg kg−1, then a continuous infusion of 2 mg kg−1 h-1). Plasma concentrations of lidocaine were measured four times during and after lidocaine infusion. Twenty subjects who underwent liver resection were analyzed. There was 35% of preexisting liver disease before tumor diagnosis, and 75% of liver resection was defined as “major hepatectomy.” Plasmatic levels of lidocaine were in the therapeutic range. No blood sample showed a concentration above the toxicity threshold: 1.6 (1.3–2.1) mg ml−1 one hour after the start of infusion, 2.5 (1.7–2.8) mg ml−1 at the end of hepatic transection, 1.7 (1.3–2.0) mg ml−1 one hour after the end of infusion, and 1.2 (0.8–1.4) mg ml−1 at the end of surgery. Comparative analysis between the presence of a preexisting liver disease or not and the association of intraoperative vascular clamping or not did not show significant difference concerning lidocaine blood levels. Perioperative lidocaine infusion seems safe in the field of liver surgery. Nevertheless, additional prospective studies need to assess the clinical usefulness in terms of analgesia and antitumoral effects.
围手术期利多卡因输注具有许多有趣的特性,例如在促进术后恢复方面的镇痛效果。然而,由于利多卡因的肝脏代谢作用,它在肝脏手术中的应用受到限制。 这项前瞻性单中心研究于 2020 年至 2021 年进行。研究对象包括接受肝脏手术的患者。他们接受利多卡因输注方案,直到肝横断开始(栓塞剂量为 1.5 毫克/公斤-1,然后持续输注 2 毫克/公斤-1 小时-1)。在利多卡因输注过程中和输注后,对利多卡因的血浆浓度进行了四次测量。 对 20 名接受肝脏切除术的受试者进行了分析。35%的受试者在肿瘤确诊前已患有肝脏疾病,75%的肝脏切除术被定义为 "主要肝切除术"。血浆中利多卡因的浓度处于治疗范围内。没有血液样本显示浓度超过毒性阈值:输液开始一小时后为 1.6 (1.3-2.1) mg ml-1,肝横断术结束时为 2.5 (1.7-2.8) mg ml-1,输液结束一小时后为 1.7 (1.3-2.0) mg ml-1,手术结束时为 1.2 (0.8-1.4) mg ml-1。对是否存在肝脏疾病以及术中是否进行血管夹闭进行比较分析后发现,利多卡因血药浓度并无显著差异。 在肝脏手术领域,围手术期输注利多卡因似乎是安全的。不过,还需要更多的前瞻性研究来评估利多卡因在镇痛和抗肿瘤方面的临床作用。
{"title":"Safety of perioperative intravenous lidocaine in liver surgery – A pilot study","authors":"Pierre Grassin, Richard Descamps, J. Bourgine, Jean Lubrano, A. Fiant, Véronique Lelong-Boulouard, J. Hanouz","doi":"10.4103/joacp.joacp_391_22","DOIUrl":"https://doi.org/10.4103/joacp.joacp_391_22","url":null,"abstract":"\u0000 \u0000 \u0000 Perioperative lidocaine infusion has many interesting properties such as analgesic effects in the context of enhanced recovery after surgery. However, its use is limited in liver surgery due to its hepatic metabolism.\u0000 \u0000 \u0000 \u0000 This prospective, monocentric study was conducted from 2020 to 2021. Patients undergoing liver surgery were included. They received a lidocaine infusion protocol until the beginning of hepatic transection (bolus dose of 1.5 mg kg−1, then a continuous infusion of 2 mg kg−1 h-1). Plasma concentrations of lidocaine were measured four times during and after lidocaine infusion.\u0000 \u0000 \u0000 \u0000 Twenty subjects who underwent liver resection were analyzed. There was 35% of preexisting liver disease before tumor diagnosis, and 75% of liver resection was defined as “major hepatectomy.” Plasmatic levels of lidocaine were in the therapeutic range. No blood sample showed a concentration above the toxicity threshold: 1.6 (1.3–2.1) mg ml−1 one hour after the start of infusion, 2.5 (1.7–2.8) mg ml−1 at the end of hepatic transection, 1.7 (1.3–2.0) mg ml−1 one hour after the end of infusion, and 1.2 (0.8–1.4) mg ml−1 at the end of surgery. Comparative analysis between the presence of a preexisting liver disease or not and the association of intraoperative vascular clamping or not did not show significant difference concerning lidocaine blood levels.\u0000 \u0000 \u0000 \u0000 Perioperative lidocaine infusion seems safe in the field of liver surgery. Nevertheless, additional prospective studies need to assess the clinical usefulness in terms of analgesia and antitumoral effects.\u0000","PeriodicalId":508221,"journal":{"name":"Journal of Anaesthesiology Clinical Pharmacology","volume":"213 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140730700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reverse (180° rotation) technique for LMA protector insertion 反向(180° 旋转)技术插入 LMA 保护器
Pub Date : 2024-04-08 DOI: 10.4103/joacp.joacp_301_22
M. Bhardwaj, Sunny Dhania, Prakriti Bishnoi, Kiranpreet Kaur
{"title":"Reverse (180° rotation) technique for LMA protector insertion","authors":"M. Bhardwaj, Sunny Dhania, Prakriti Bishnoi, Kiranpreet Kaur","doi":"10.4103/joacp.joacp_301_22","DOIUrl":"https://doi.org/10.4103/joacp.joacp_301_22","url":null,"abstract":"","PeriodicalId":508221,"journal":{"name":"Journal of Anaesthesiology Clinical Pharmacology","volume":"3 s1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140728864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of tramadol as an adjuvant in ultrasound-guided serratus anterior muscle block for modified radical mastectomy - A randomized control trial 曲马多作为改良根治性乳房切除术超声引导下前锯肌阻滞的辅助药物的作用--随机对照试验
Pub Date : 2024-04-08 DOI: 10.4103/joacp.joacp_436_22
Vaishali Singla, S. Palta, R. Saroa, Robin Kaushik, Avneet Singh
Modified radical mastectomy (MRM) is associated with significant acute post-operative pain that may progress to chronic pain syndromes in 25–60% of patients. Serratus anterior muscle (SAM) block has proved to be an excellent analgesic option in patients undergoing MRM. Although many adjuvants have been utilized for the prolongation of analgesia, the role of tramadol in SAM has not been studied as yet. We hypothesize that the addition of tramadol to ropivacaine for SAM block may reduce morphine consumption in the post-operative period in patients undergoing elective MRM surgeries. The primary aim of the study was to compare cumulative post-operative morphine consumption over 24 h in patients receiving SAM block with or without tramadol. The secondary aims were to observe adverse events related to the procedure or medications. The other parameters recorded were non-invasive blood pressure (NIBP), pulse rate, respiratory rate, and nausea or vomiting. Patients scheduled to undergo MRM were randomly allocated by block randomization into two groups. The study group (Group T) received a SAM block with 0.25% ropivacaine (18 ml) with tramadol 100 mg while the control group (Group P) received a SAM block with 18 ml of 0.25% ropivacaine and 2 ml of saline. Patients were assessed for pain scores, analgesic requirement, time to first analgesic request, hemodynamic variables, and any side-effects at 30 min, 1 h, 4 h, 8 h, 12 h, and 24 h post-operatively. Cumulative morphine consumption over 24 h in the post-operative period was less in the group T (3.06 ± 1.53 mg vs 4.34 ± 1.53 mg; P 0.001). Time to the first analgesic requirement was more in group T (10.44 ± 5.04 h vs 6.11 ± 2.73 h; P < 0.001). Pain scores were significantly lower in the group T at all time points. Tramadol, when used as an adjuvant to ropivacaine for SAM block reduces post-operative pain scores in the first 24 h and prolongs the time of first morphine requirement.
改良根治性乳房切除术(MRM)会导致严重的术后急性疼痛,25%-60%的患者可能会发展为慢性疼痛综合征。事实证明,前锯肌 (SAM) 阻滞对接受乳腺癌根治术的患者来说是一种极佳的镇痛选择。虽然许多辅助剂被用于延长镇痛时间,但曲马多在 SAM 中的作用尚未得到研究。我们假设,在罗哌卡因中加入曲马多用于 SAM 阻滞,可能会减少接受 MRM 手术的择期患者术后的吗啡用量。本研究的主要目的是比较接受SAM阻滞时添加或不添加曲马多的患者术后24小时内的吗啡累积消耗量。次要目的是观察与手术或药物相关的不良事件。记录的其他参数包括无创血压(NIBP)、脉搏、呼吸频率、恶心或呕吐。 计划接受 MRM 的患者通过整群随机法被随机分配到两组。研究组(T 组)接受 0.25% 罗哌卡因(18 毫升)和曲马多 100 毫克的 SAM 阻滞,而对照组(P 组)接受 18 毫升 0.25% 罗哌卡因和 2 毫升生理盐水的 SAM 阻滞。分别在术后 30 分钟、1 小时、4 小时、8 小时、12 小时和 24 小时对患者的疼痛评分、镇痛需求、首次镇痛请求时间、血液动力学变量和任何副作用进行评估。 T 组在术后 24 小时内的累积吗啡消耗量较少(3.06 ± 1.53 毫克 vs 4.34 ± 1.53 毫克;P 0.001)。T 组患者首次需要镇痛药的时间更长(10.44 ± 5.04 小时 vs 6.11 ± 2.73 小时;P < 0.001)。在所有时间点上,T 组的疼痛评分都明显较低。 曲马多作为罗哌卡因的辅助药物用于SAM阻滞时,可降低术后头24小时的疼痛评分,并延长首次吗啡需求时间。
{"title":"Role of tramadol as an adjuvant in ultrasound-guided serratus anterior muscle block for modified radical mastectomy - A randomized control trial","authors":"Vaishali Singla, S. Palta, R. Saroa, Robin Kaushik, Avneet Singh","doi":"10.4103/joacp.joacp_436_22","DOIUrl":"https://doi.org/10.4103/joacp.joacp_436_22","url":null,"abstract":"\u0000 \u0000 \u0000 Modified radical mastectomy (MRM) is associated with significant acute post-operative pain that may progress to chronic pain syndromes in 25–60% of patients. Serratus anterior muscle (SAM) block has proved to be an excellent analgesic option in patients undergoing MRM. Although many adjuvants have been utilized for the prolongation of analgesia, the role of tramadol in SAM has not been studied as yet. We hypothesize that the addition of tramadol to ropivacaine for SAM block may reduce morphine consumption in the post-operative period in patients undergoing elective MRM surgeries. The primary aim of the study was to compare cumulative post-operative morphine consumption over 24 h in patients receiving SAM block with or without tramadol. The secondary aims were to observe adverse events related to the procedure or medications. The other parameters recorded were non-invasive blood pressure (NIBP), pulse rate, respiratory rate, and nausea or vomiting.\u0000 \u0000 \u0000 \u0000 Patients scheduled to undergo MRM were randomly allocated by block randomization into two groups. The study group (Group T) received a SAM block with 0.25% ropivacaine (18 ml) with tramadol 100 mg while the control group (Group P) received a SAM block with 18 ml of 0.25% ropivacaine and 2 ml of saline. Patients were assessed for pain scores, analgesic requirement, time to first analgesic request, hemodynamic variables, and any side-effects at 30 min, 1 h, 4 h, 8 h, 12 h, and 24 h post-operatively.\u0000 \u0000 \u0000 \u0000 Cumulative morphine consumption over 24 h in the post-operative period was less in the group T (3.06 ± 1.53 mg vs 4.34 ± 1.53 mg; P 0.001). Time to the first analgesic requirement was more in group T (10.44 ± 5.04 h vs 6.11 ± 2.73 h; P < 0.001). Pain scores were significantly lower in the group T at all time points.\u0000 \u0000 \u0000 \u0000 Tramadol, when used as an adjuvant to ropivacaine for SAM block reduces post-operative pain scores in the first 24 h and prolongs the time of first morphine requirement.\u0000","PeriodicalId":508221,"journal":{"name":"Journal of Anaesthesiology Clinical Pharmacology","volume":"39 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140732067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility of opioid-free anesthesia in laparoscopic radical prostatectomy: A retrospective, quasi-experimental study 腹腔镜前列腺癌根治术中无阿片麻醉的可行性:一项回顾性准实验研究
Pub Date : 2024-04-08 DOI: 10.4103/joacp.joacp_375_23
A. Tejedor, Lana Bijelic, Marta García
Opioid-free anesthesia (OFA) provides adequate analgesia minimizing opioids. OFA has not been evaluated in laparoscopic radical prostatectomy (LRP). Our aim was to evaluate OFA feasibility and its effectiveness in LRP. A quasi-experimental retrospective study of 55 adult patients undergoing LRP was performed from September 2020 until December 20223. Predefined protocols for either opioid-based anesthesia (OBA; with continuous remifentanil infusion) or OFA (continuous lidocaine, dexmedetomidine, and ketamine infusion) were followed. In both groups, wound infiltration was performed before skin incision. Primary outcome was postoperative pain management (numerical rating scale [NRS]) in the first 24 postoperative hours. Secondary outcomes were opioid consumption, start to sitting and ambulation, postoperative complications, and length of hospital stay. OFA protocol patients had better median pain scores during movement at 1, 18 and 24 h, that is, 1 (interquartile range [IQR] 0–3) versus 2.5 (IQR 0–4), P = 0.047; 0 (IQR 0–1) versus 1 (IQR 0–2), P = 0.017; and 0 (IQR 0–0.25) versus 1 (IQR 0–2), P = 0.013, respectively. At 6 and 12 h, there were no statistically significant differences, that is, 0.5 (IQR 0–2) versus 1 (IQR 0–2), P = 0.908 and 1 (IQR 0–2) versus 0.5 (IQR 0–2), P = 0.929, respectively. Lower morphine requirements were recorded in the first 18 and 24 postoperative hours, that is, 0 (IQR 0–0) versus 1 (IQR 0–2.75) mg, P = 0.028 and 0 (IQR 0–2) versus 1.5 (IQR 0–3) mg, P = 0.012, respectively. Start to sitting and ambulation occurred earlier in the OFA group (P = 0.030 and P = 0.002, respectively). Linear regression showed that ambulation was independently associated with the analgesic technique (P = 0.034). Only one patient had postoperative nausea and vomiting (PONV) and belonged to the OBA group. There was no difference in total complications or the length of stay. In this study, OFA strategy was found to be safe, feasible, and provided adequate analgesia, minimizing the use of postoperative opioids, and was independently associated with earlier ambulation.
无阿片麻醉(OFA)可提供充分的镇痛,最大限度地减少阿片类药物的用量。无阿片麻醉尚未在腹腔镜前列腺癌根治术(LRP)中进行过评估。我们的目的是评估 OFA 在前列腺癌根治术中的可行性和有效性。 从 2020 年 9 月到 2022 年 12 月,我们对 55 名接受前列腺癌根治术的成年患者进行了一项准实验性回顾研究3。研究人员按照预定方案进行了阿片类药物麻醉(OBA,持续输注瑞芬太尼)或 OFA(持续输注利多卡因、右美托咪定和氯胺酮)。两组均在切开皮肤前进行伤口浸润。主要结果是术后 24 小时内的疼痛控制情况(数字评分量表 [NRS])。次要结果是阿片类药物的用量、开始坐立和行走的时间、术后并发症和住院时间。 OFA方案患者在1、18和24小时内活动时的中位疼痛评分较好,分别为1(四分位距[IQR] 0-3)对2.5(IQR 0-4),P = 0.047;0(IQR 0-1)对1(IQR 0-2),P = 0.017;0(IQR 0-0.25)对1(IQR 0-2),P = 0.013。在 6 小时和 12 小时内,差异无统计学意义,分别为 0.5(IQR 0-2)对 1(IQR 0-2),P = 0.908 和 1(IQR 0-2)对 0.5(IQR 0-2),P = 0.929。术后最初18小时和24小时的吗啡需求量较低,分别为0(IQR 0-0)对1(IQR 0-2.75)毫克,P = 0.028和0(IQR 0-2)对1.5(IQR 0-3)毫克,P = 0.012。OFA 组开始坐立和行走的时间更早(P = 0.030 和 P = 0.002)。线性回归显示,行走与镇痛技术有独立关联(P = 0.034)。只有一名患者出现术后恶心和呕吐(PONV),属于OBA组。总并发症和住院时间没有差异。 本研究发现,OFA策略安全、可行,能提供充分的镇痛,最大限度地减少术后阿片类药物的使用,并且与患者更早下床活动密切相关。
{"title":"Feasibility of opioid-free anesthesia in laparoscopic radical prostatectomy: A retrospective, quasi-experimental study","authors":"A. Tejedor, Lana Bijelic, Marta García","doi":"10.4103/joacp.joacp_375_23","DOIUrl":"https://doi.org/10.4103/joacp.joacp_375_23","url":null,"abstract":"\u0000 \u0000 \u0000 Opioid-free anesthesia (OFA) provides adequate analgesia minimizing opioids. OFA has not been evaluated in laparoscopic radical prostatectomy (LRP). Our aim was to evaluate OFA feasibility and its effectiveness in LRP.\u0000 \u0000 \u0000 \u0000 A quasi-experimental retrospective study of 55 adult patients undergoing LRP was performed from September 2020 until December 20223. Predefined protocols for either opioid-based anesthesia (OBA; with continuous remifentanil infusion) or OFA (continuous lidocaine, dexmedetomidine, and ketamine infusion) were followed. In both groups, wound infiltration was performed before skin incision. Primary outcome was postoperative pain management (numerical rating scale [NRS]) in the first 24 postoperative hours. Secondary outcomes were opioid consumption, start to sitting and ambulation, postoperative complications, and length of hospital stay.\u0000 \u0000 \u0000 \u0000 OFA protocol patients had better median pain scores during movement at 1, 18 and 24 h, that is, 1 (interquartile range [IQR] 0–3) versus 2.5 (IQR 0–4), P = 0.047; 0 (IQR 0–1) versus 1 (IQR 0–2), P = 0.017; and 0 (IQR 0–0.25) versus 1 (IQR 0–2), P = 0.013, respectively. At 6 and 12 h, there were no statistically significant differences, that is, 0.5 (IQR 0–2) versus 1 (IQR 0–2), P = 0.908 and 1 (IQR 0–2) versus 0.5 (IQR 0–2), P = 0.929, respectively. Lower morphine requirements were recorded in the first 18 and 24 postoperative hours, that is, 0 (IQR 0–0) versus 1 (IQR 0–2.75) mg, P = 0.028 and 0 (IQR 0–2) versus 1.5 (IQR 0–3) mg, P = 0.012, respectively. Start to sitting and ambulation occurred earlier in the OFA group (P = 0.030 and P = 0.002, respectively). Linear regression showed that ambulation was independently associated with the analgesic technique (P = 0.034). Only one patient had postoperative nausea and vomiting (PONV) and belonged to the OBA group. There was no difference in total complications or the length of stay.\u0000 \u0000 \u0000 \u0000 In this study, OFA strategy was found to be safe, feasible, and provided adequate analgesia, minimizing the use of postoperative opioids, and was independently associated with earlier ambulation.\u0000","PeriodicalId":508221,"journal":{"name":"Journal of Anaesthesiology Clinical Pharmacology","volume":"13 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140728593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Awake video laryngoscopy as a rescue airway maneuver after a failed awake flexible bronchoscope-guided intubation: A case report 清醒视频喉镜作为清醒软支气管镜引导插管失败后的气道抢救手段:病例报告
Pub Date : 2024-04-08 DOI: 10.4103/joacp.joacp_331_23
Neha Garg, Rudranil Nandi, S. Banerjee, Aditi Gupta
{"title":"Awake video laryngoscopy as a rescue airway maneuver after a failed awake flexible bronchoscope-guided intubation: A case report","authors":"Neha Garg, Rudranil Nandi, S. Banerjee, Aditi Gupta","doi":"10.4103/joacp.joacp_331_23","DOIUrl":"https://doi.org/10.4103/joacp.joacp_331_23","url":null,"abstract":"","PeriodicalId":508221,"journal":{"name":"Journal of Anaesthesiology Clinical Pharmacology","volume":"180 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140731075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Anaesthesiology Clinical Pharmacology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1